REBECCA EDWARDS: Open Payments
NPI 1922016658 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,970 in 118 payments from 19 companies in 2025. Trend: 2023 $2,375 · 2024 $2,376 · 2025 $1,970
Food & beverage: $1,970
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $355 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $302 |
| LEO Pharma Inc. | 10 | $234 |
| Galderma Laboratories, L.P. | 22 | $150 |
| Lilly USA, LLC | 8 | $147 |
| Novartis Pharmaceuticals Corporation | 5 | $129 |
| PFIZER INC. | 7 | $118 |
| Arcutis Biotherapeutics, Inc. | 5 | $84 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
Products named: ADBRY, SKYRIZI, RINVOQ, ILUMYA, EBGLYSS, CIBINQO, COSENTYX, Zoryve.
Industry payments across AL — which companies pay providers there.
